Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 89INDUSTRY 18NIH 11NETWORK 4OTHER_GOV 1

Study Type

Interventional 8Observational 1

Sponsor

Cancer Type

Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Neoplasms 72Breast Neoplasms 71Colorectal Neoplasms 42Prostatic Neoplasms 35Lung Neoplasms 30Stomach Neoplasms 27Uterine Cervical Neoplasms 25Carcinoma, Non-Small-Cell Lung 22Endometrial Neoplasms 20Ovarian Neoplasms 19Carcinoma, Hepatocellular 19Rectal Neoplasms 18Thyroid Neoplasms 16Colonic Neoplasms 16Urinary Bladder Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Pancreatic Neoplasms 15Esophageal Neoplasms 14Multiple Myeloma 12Gastrointestinal Neoplasms 11Recurrence 10Neoplasm Metastasis 10Sarcopenia 9Obesity 9Leukemia, Myeloid, Acute 9Disease 9Thyroid Cancer, Papillary 8Polycystic Ovary Syndrome 8Melanoma 8Lymphoma 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Observational × Myelodysplastic Syndromes × Clear all
NCT06944119 2025-07-28

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Tel-Aviv Sourasky Medical Center

Active not recruiting
250 enrolled
LymphoidMyeloidPlasma cell

Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡